View Older Stories

Jun 11, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)

Apr 11, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)

Apr 11, 2025 06:37AM H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)

Apr 4, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)

Apr 1, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Talphera (TLPH)

Apr 1, 2025 06:46AM Unicycive Therapeutics (UNCY) PT Raised to $7.50 at H.C. Wainwright

Mar 17, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)

Mar 12, 2025 06:41AM Aligos Therapeutics Inc. (ALGS) PT Lowered to $70 at H.C. Wainwright

Mar 10, 2025 06:45AM Cidara Therapeutics (CDTX) PT Raised to $35 at H.C. Wainwright

Mar 10, 2025 06:44AM Arcturus Therapeutics (ARCT) PT Lowered to $60 at H.C. Wainwright

Mar 3, 2025 06:41AM 89bio Inc. (ETNB) PT Lowered to $21 at H.C. Wainwright

Mar 3, 2025 06:15AM Akero Therapeutics (AKRO) PT Raised to $75 at H.C. Wainwright

Feb 28, 2025 07:12AM Mirum Pharamceuticals (MIRM) PT Raised to $72 at H.C. Wainwright

Feb 21, 2025 06:48AM H.C. Wainwright Reiterates Neutral Rating on Ardelyx, Inc (ARDX)

Feb 19, 2025 07:13AM H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Feb 18, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)

Feb 11, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)

Feb 10, 2025 06:04AM H.C. Wainwright Downgrades Pliant Therapeutics (PLRX) to Neutral

Feb 3, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)

Jan 27, 2025 11:47AM Akero Therapeutics (AKRO) PT Raised to $72 at H.C. Wainwright

Jan 24, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)

Jan 21, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on 89bio Inc. (ETNB)

Jan 17, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Akero Therapeutics (AKRO)

Jan 15, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)

Jan 14, 2025 11:06AM H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)

Jan 7, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)

Dec 30, 2024 06:07AM H.C. Wainwright Starts MetaVia (MTVA) at Buy

Dec 30, 2024 06:06AM H.C. Wainwright Starts NewAmsterdam Pharma Co NV (NAMS) at Buy

Dec 27, 2024 12:32PM H.C. Wainwright Downgrades Galectin Therapeutics (GALT) to Neutral

Dec 27, 2024 06:56AM H.C. Wainwright Reiterates Neutral Rating on Assembly Biosciences (ASMB)

Dec 24, 2024 06:51AM H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Dec 24, 2024 06:50AM Enanta Pharmaceuticals (ENTA) PT Lowered to $18 at H.C. Wainwright

Dec 17, 2024 06:53AM H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)

Nov 13, 2024 06:59AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)

Nov 12, 2024 07:52AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)

Nov 11, 2024 08:35AM H.C. Wainwright Reiterates Buy Rating on Pliant Therapeutics (PLRX)

Nov 11, 2024 06:21AM H.C. Wainwright Downgrades Ardelyx, Inc (ARDX) to Neutral

Nov 6, 2024 06:44AM Ultragenyx Pharma (RARE) PT Raised to $95 at H.C. Wainwright

Oct 16, 2024 06:38AM Inventiva SA (IVA) PT Lowered to $13 at H.C. Wainwright

Oct 11, 2024 06:37AM H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)

Oct 11, 2024 06:36AM H.C. Wainwright Reiterates Buy Rating on Genfit (GNFT)

Oct 11, 2024 06:35AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharamceuticals (MIRM), 'affirm MIRM shares as one of our 2024 Top Picks'

Oct 10, 2024 06:58AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)

Oct 10, 2024 06:57AM H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)

Oct 8, 2024 06:49AM H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)

Oct 2, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)

Sep 27, 2024 06:44AM Inventiva SA (IVA) PT Lowered to $14 at H.C. Wainwright

Sep 27, 2024 06:43AM Travere Therapeutics (TVTX) PT Lowered to $18 at H.C. Wainwright

Sep 26, 2024 06:45AM H.C. Wainwright Reiterates Neutral Rating on Durect Corp (DRRX)

Sep 24, 2024 06:51AM H.C. Wainwright Reiterates Neutral Rating on Assembly Biosciences (ASMB)

View Older Stories